Journal profile · Immunology
Journal of Autoimmunity
ISSN 0896-8411 · eISSN 1095-9157 · Academic Press Inc. · ENGLAND · Bimonthly · Founded 1988
Journal of Autoimmunity: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 6.82; hybrid open access; APC about USD 5,420; median 90 days to acceptance (104 articles, last 24 months); community-reported acceptance: fairly hard; 113 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Autoimmunity is published by Academic Press Inc. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are T-cell and B-cell Immunology, Diabetes and associated disorders and Immune Cell Function and Interaction, together about 35.5% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Autoimmunity is a parent journal of the Journal of Translational Autoimmunity . The Journal of Autoimmunity publishes papers related to the diverse aspects of autoimmunity: the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic autoantibody tests, and the epidemiology, pathophysiology, and treatment of autoimmune diseases. Special, but not exclusive, attention will be given to papers dealing with genetic, molecular biology, and cellular aspects of the discipline.Research Areas Include:• Underlying mechanisms of autoimmunity • Immunologic • Molecular • Cellular • Genetic • VirologicAreas of Clinical Interest:• Rheumatology • Dermatology • Endocrinology • Nephrology • Haematology • Immunopharmacology
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Carlo SelmiPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 11, Italy 9, France 6, United Kingdom 2, Japan 2 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- T-cell and B-cell ImmunologyImmunology and Microbiology14.8%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology10.4%
- Immune Cell Function and InteractionImmunology and Microbiology10.3%
- Systemic Lupus Erythematosus ResearchMedicine10%
- Monoclonal and Polyclonal Antibodies ResearchMedicine7.4%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.6%
- Pancreatic function and diabetesMedicine4.6%
- Salivary Gland Disorders and FunctionsMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.82LetPub ·
- Impact factor (publisher)
- 6.8Publisher website ·
- CiteScore 2026-06
- 13.6LetPub ·
- CiteScore (publisher)
- 13.6Publisher website ·
- SJR 2026-06
- 2.3LetPub ·
- SNIP 2026-06
- 1.63LetPub ·
- h-index
- 101LetPub ·
- h-index
- 175OpenAlex ·
- i10-index
- 3,007OpenAlex ·
- 2-year mean citedness
- 6.88OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 48.47%LetPub ·
Volume
- Articles per year
- 103LetPub ·
Articles by year OpenAlex count · 4,473 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 79 | 48 | 26 |
| 2025 | 113 | 69 | 564 |
| 2024 | 143 | 95 | 1,715 |
| 2023 | 126 | 84 | 2,668 |
| 2022 | 133 | 76 | 4,769 |
| 2021 | 112 | 78 | 4,993 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
90 daysMedian, submission to acceptance · P25–P75 68 days – 113 days
- Acceptance to online
- median 9 days (104 articles)
- Submission to online
- median 99 days
- Sample
- 104 articles with submission and acceptance dates (227 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 31 daysPublisher website ·
- Submission to acceptance
- 103 daysPublisher website ·
- Acceptance to publication
- 8 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,420 / EUR 5,070 / GBP 4,340 / JPY 672,240 | — | — | |
| Publisher website | USD 5,030 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7, with length limits
- original researchThe Journal of Autoimmunity will accept articles in the following categories: Research paper; Short Communication; Review Article.Full-length articles are full-…Length not stated
- original research articleThe Journal of Autoimmunity will accept articles in the following categories: Research paper; Short Communication; Review Article.Full-length articles are full-…main text ≤ 5,000 words
- research articleThe Journal of Autoimmunity will accept articles in the following categories: Research paper; Short Communication; Review Article.Full-length articles are full-…Length not stated
- research paperThe Journal of Autoimmunity will accept articles in the following categories: Research paper; Short Communication; Review Article.Full-length articles are full-…Length not stated
- reviewThe Journal of Autoimmunity will accept articles in the following categories: Research paper; Short Communication; Review Article.Full-length articles are full-…Length not stated
- review articleThe Journal of Autoimmunity will accept articles in the following categories: Research paper; Short Communication; Review Article.Full-length articles are full-…Length not stated
- short communicationThe Journal of Autoimmunity will accept articles in the following categories: Research paper; Short Communication; Review Article.Full-length articles are full-…main text ≤ 2,500 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Academic Press Inc.
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1988
- ISSN
- 0896-8411
- Electronic ISSN
- 1095-9157
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Autoimmunity
What CAS zone is Journal of Autoimmunity in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Autoimmunity is in Zone 1 of Medicine, and in Zone 1 of the minor category Immunology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Autoimmunity?
The latest impact factor listed by LetPub is 6.82; CiteScore 13.6, h-index 175.
How long does peer review take at Journal of Autoimmunity?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 68–113 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Autoimmunity based?
Of the 41 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (11), Italy (9) and France (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Autoimmunity?
According to LetPub and DOAJ records, Journal of Autoimmunity is indexed in SCIE and Scopus.
Is Journal of Autoimmunity open access, and what is the APC?
Journal of Autoimmunity is a hybrid journal. For open-access publication: APC about USD 5,420.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .